We are proud to announce that PhenoPath is now a Quest Diagnostics Company.
IHC
Methodology: IHC
Clinical Significance:
Identifies: A transmembrane protein that is a specific marker of transitional cell epithelium and tumors. While highly specific, uroplakin is a marker of low sensitivity for urothelial carcinomas.
Subcellular Localization: Membranous
Organ: Genitourinary Tumors
Disease State: Carcinomas of Unknown Primary
CPT Code(s): 88342 or 88341 (reference only; CPTs may vary)
Turnaround Time: Within 1-2 business days of receipt
Schedule: Monday - Friday
Specimen Requirements:
• Formalin-fixed, paraffin-embedded (FFPE) tissue block or cell block - OR -
• 1 unstained slide for each test requested plus 3-4 additional unstained slides cut at 4µm